Lazertinib
id:
lazertinib-180-728748
title:
Lazertinib
text:
Lazertinib, sold under the brand name Lazcluze and Leclaza, is an anti-cancer medication used for the treatment of non-small cell lung cancer. It is a kinase inhibitor of epidermal growth factor receptor. The most common adverse reactions include rash, nail toxicity, infusion-related reactions (amivantamab), musculoskeletal pain, edema, stomatitis, venous thromboembolism, paresthesia, fatigue, diarrhea, constipation, COVID-19 infection, hemorrhage, dry skin, decreased appetite, pruritus, nausea,
brand slug:
wiki
category slug:
encyclopedia
description:
Anti-cancer medication
original url:
https://en.wikipedia.org/wiki/Lazertinib
date created:
2024-08-21T04:23:17Z
date modified:
2024-09-05T05:42:49Z
main entity:
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/e/e9/Lazertinib.svg","width":512,"height":331}
fields total:
13
integrity:
15